Plenteous Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-06-2024
- Paid Up Capital ₹ 0.50 M
as on 16-06-2024
- Company Age 15 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 450.00 M
as on 16-06-2024
- Satisfied Charges ₹ 20.00 M
as on 16-06-2024
- Revenue -33.77%
(FY 2023)
- Profit -510.21%
(FY 2023)
- Ebitda -225.14%
(FY 2023)
- Net Worth -119.00%
(FY 2023)
- Total Assets -28.43%
(FY 2023)
About Plenteous Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹45.00 Cr. The company has closed loans amounting to ₹2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pooja Sharma, Dhara Tiwari, and Kusum Sharma serve as directors at the Company.
- CIN/LLPIN
U24232DL2008PLC185686
- Company No.
185686
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2008
- Date of AGM
18 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Plenteous Pharmaceuticals Limited offer?
Plenteous Pharmaceuticals Limited offers a wide range of products and services, including Specialty Supplements, Probiotics, Vitamins & Supplements, Multivitamins.
Who are the key members and board of directors at Plenteous Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Sharma  | Whole-Time Director | 24-Nov-2017 | Current |
| Dhara Tiwari | Director | 07-Dec-2013 | Current |
| Kusum Sharma | Director | 29-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Plenteous Pharmaceuticals.
Plenteous Pharmaceuticals Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 33.77% decrease. The company also saw a substantial fall in profitability, with a 510.21% decrease in profit. The company's net worth observed a substantial decline by a decrease of 119%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Plenteous Pharmaceuticals?
In 2023, Plenteous Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
15 years 8 months 
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Jp Morgan Chase Bank, N.A. Creation Date: 10 Mar 2023 | ₹40.00 Cr | Open |
Hdfc Bank Limited Creation Date: 29 Jun 2019 | ₹5.00 Cr | Open |
Icici Bank Limited Creation Date: 12 Dec 2011 | ₹2.00 Cr | Satisfied |
How Many Employees Work at Plenteous Pharmaceuticals?
Unlock and access historical data on people associated with Plenteous Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Plenteous Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Plenteous Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
